Literature DB >> 20087791

The pathogenesis of systemic sclerosis revisited.

Matthias Geyer1, Ulf Müller-Ladner.   

Abstract

Although infectiological stimuli, environmental factors and genotypic features are known to contribute to the initiation and perpetuation of systemic sclerosis (SSc), its etiology still remains to be enigmatic, and less elusive insights are to be achieved by ongoing and future investigations. Being characterized, however, as chronic autoimmune disease with excessive collagen accumulation in skin, synovia and visceral organs such as lung, heart, and digestive tract along with obliterating angiopathy, the pathophysiology of SSc can be summarized as being based on imbalances of the cellular and humoral immune system, vascular dysfunction and activation of resident connective tissue cells. A complex interplay between these major components manages to establish and maintain the inability of the vasculature to adequately react to the need for dilatation, constriction and growth of new vessels, to cause the increased deposition of extracellular matrix constituents as well as to facilitate immunological disarrangement. Despite parallels to the chicken and egg causality dilemma, all of these account for what later clinicians observe in patients suffering from Raynaud's phenomenon, digital ulcers, sclerodactyly, rigidity of the face, microstomia, sicca syndrome, dyspnea, dry cough, pulmonary hypertension, palpitations, syncopes, renal insufficiency, dysphagia, gastroesophageal reflux, dyspepsia, generalized arthralgias, but also dyspareunia, or erectile dysfunction.

Entities:  

Mesh:

Year:  2011        PMID: 20087791     DOI: 10.1007/s12016-009-8193-3

Source DB:  PubMed          Journal:  Clin Rev Allergy Immunol        ISSN: 1080-0549            Impact factor:   8.667


  107 in total

1.  Fli-1 inhibits collagen type I production in dermal fibroblasts via an Sp1-dependent pathway.

Authors:  J Czuwara-Ladykowska; F Shirasaki; P Jackers; D K Watson; M Trojanowska
Journal:  J Biol Chem       Date:  2001-03-16       Impact factor: 5.157

Review 2.  Genetic factors in the etiology of systemic sclerosis and Raynaud phenomenon.

Authors:  F K Tan; F C Arnett
Journal:  Curr Opin Rheumatol       Date:  2000-11       Impact factor: 5.006

3.  Circulating gamma/delta T lymphocytes from systemic sclerosis (SSc) patients display a T helper (Th) 1 polarization.

Authors:  R Giacomelli; P Cipriani; A Fulminis; G Barattelli; M Matucci-Cerinic; S D'Alò; G Cifone; G Tonietti
Journal:  Clin Exp Immunol       Date:  2001-08       Impact factor: 4.330

4.  Defective vasculogenesis in systemic sclerosis.

Authors:  Masataka Kuwana; Yuka Okazaki; Hidekata Yasuoka; Yutaka Kawakami; Yasuo Ikeda
Journal:  Lancet       Date:  2004 Aug 14-20       Impact factor: 79.321

Review 5.  Mechanisms of vascular damage in systemic sclerosis.

Authors:  Ulf Müller-Ladner; Oliver Distler; Lidia Ibba-Manneschi; Elena Neumann; Steffen Gay
Journal:  Autoimmunity       Date:  2009-11       Impact factor: 2.815

6.  Modulation of human alpha1(I) procollagen gene activity by interaction with Sp1 and Sp3 transcription factors in vitro.

Authors:  S J Chen; C M Artlett; S A Jimenez; J Varga
Journal:  Gene       Date:  1998-07-17       Impact factor: 3.688

7.  Introduction of the interleukin-10 gene into mice inhibited bleomycin-induced lung injury in vivo.

Authors:  T Arai; K Abe; H Matsuoka; M Yoshida; M Mori; S Goya; H Kida; K Nishino; T Osaki; I Tachibana; Y Kaneda; S Hayashi
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2000-05       Impact factor: 5.464

Review 8.  Genetic and environmental factors in systemic sclerosis.

Authors:  R I Fox; H I Kang
Journal:  Curr Opin Rheumatol       Date:  1992-12       Impact factor: 5.006

9.  STAT4 is a genetic risk factor for systemic sclerosis having additive effects with IRF5 on disease susceptibility and related pulmonary fibrosis.

Authors:  P Dieudé; M Guedj; J Wipff; B Ruiz; E Hachulla; E Diot; B Granel; J Sibilia; K Tiev; L Mouthon; J L Cracowski; P H Carpentier; Z Amoura; I Fajardy; J Avouac; O Meyer; A Kahan; C Boileau; Y Allanore
Journal:  Arthritis Rheum       Date:  2009-08

Review 10.  Vasculopathy and disordered angiogenesis in selected rheumatic diseases: rheumatoid arthritis and systemic sclerosis.

Authors:  Alisa E Koch; Oliver Distler
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

View more
  24 in total

Review 1.  N-TproBNP as biomarker in systemic sclerosis.

Authors:  Tommaso Schioppo; Carolina Artusi; Teresa Ciavarella; Francesca Ingegnoli; Antonella Murgo; Silvana Zeni; Cecilia Chighizola; Pier Luigi Meroni
Journal:  Clin Rev Allergy Immunol       Date:  2012-12       Impact factor: 8.667

2.  Technical feasibility of real-time elastography to assess the peri-oral region in patients affected by systemic sclerosis.

Authors:  Paola Maria Cannaò; Valeriano Vinci; Fabio Caviggioli; Marco Klinger; Davide Orlandi; Francesco Sardanelli; Giovanni Serafini; Luca Maria Sconfienza
Journal:  J Ultrasound       Date:  2014-07-29

3.  Membrane array and multiplex bead analysis of tear cytokines in systemic sclerosis.

Authors:  Aniko Rentka; Jolan Harsfalvi; Gabriella Szucs; Zoltan Szekanecz; Peter Szodoray; Krisztina Koroskenyi; Adam Kemeny-Beke
Journal:  Immunol Res       Date:  2016-04       Impact factor: 2.829

4.  Clinical Efficacy and Safety of Bathing with Chinese Medicine Taohong Siwu Decoction () for Treatment of Diffuse Cutaneous Systemic Sclerosis: A Randomized Placebo-Controlled Trial.

Authors:  Jing Zhou; Dong Yang; Shu-Hong Zhou; Jin-Ping Wang; Yue-Shu Liu; Shu-Lan Wang
Journal:  Chin J Integr Med       Date:  2017-02-15       Impact factor: 1.978

5.  [Nailfold capillaroscopy].

Authors:  M Geyer; M Vasile; W Hermann
Journal:  Z Rheumatol       Date:  2014-03       Impact factor: 1.372

Review 6.  The sex bias in systemic sclerosis: on the possible mechanisms underlying the female disease preponderance.

Authors:  Fabio D'Amico; Evangelia Skarmoutsou; Maria Clorinda Mazzarino
Journal:  Clin Rev Allergy Immunol       Date:  2014-12       Impact factor: 8.667

7.  [Intracellular signaling transduction pathways. Potential targets in the treatment of rheumatic diseases].

Authors:  K W Frommer; M Geyer; G S Firestein
Journal:  Z Rheumatol       Date:  2012-08       Impact factor: 1.372

8.  Disease modification in systemic sclerosis. Do integrated approaches offer new challenges?

Authors:  M Cutolo
Journal:  Z Rheumatol       Date:  2013-05       Impact factor: 1.372

9.  Heart involvement in systemic sclerosis: a combined echocardiographic and scintigraphic study.

Authors:  Charalampos Papagoras; Kerstin Achenbach; Niki Tsifetaki; Spyridon Tsiouris; Andreas Fotopoulos; Alexandros A Drosos
Journal:  Clin Rheumatol       Date:  2014-05-22       Impact factor: 2.980

10.  Global chemokine expression in systemic sclerosis (SSc): CCL19 expression correlates with vascular inflammation in SSc skin.

Authors:  Allison L Mathes; Romy B Christmann; Giuseppina Stifano; Alsya J Affandi; Timothy R D J Radstake; G Alessandra Farina; Cristina Padilla; Sarah McLaughlin; Robert Lafyatis
Journal:  Ann Rheum Dis       Date:  2013-07-19       Impact factor: 19.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.